NCT06177249View on ClinicalTrials.gov

To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,956

Participants

Timeline

Start Date

March 15, 2015

Primary Completion Date

December 16, 2015

Study Completion Date

May 1, 2016

Conditions
Rabies Human
Interventions
BIOLOGICAL

Control vaccine

A group of 652 subjects were vaccinated with the control vaccine at 0, 3, 7, 14 and 28 days (5 doses in total). Blood samples were collected from the subjects at 0, 7/14 and 35/42 days for antibody detection.

BIOLOGICAL

Experimental vaccine

A total of 652 subjects received 5 doses of the vaccine at 0, 3, 7, 14 and 28 days. Blood samples were collected on 0, 7/14 and 35/42 days for antibody detection.

Trial Locations (1)

450000

Xia Shengli, Zhengzhou

All Listed Sponsors
collaborator

Henan Center for Disease Control and Prevention

OTHER_GOV

lead

Hualan Biological Bacterin Co. Ltd.

INDUSTRY

NCT06177249 - To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell) | Biotech Hunter | Biotech Hunter